Covid drives historic demand for life sciences real estate and these REITs, report says

  • Venture-capital investment in the life sciences sector grew to a record rolling annual total of $17.8 billion in the second quarter.
  • Covid-19 is accelerating an already growing demand for real estate in the sector.
  • “The biotech sector may be the single most attractive subsector within commercial real estate today,” said Spencer Levy, chairman of Americas research and senior economic advisor for CBRE.



a person standing in a room: Research associate Sachi Johnson works at Sorrento Therapeutics where efforts are underway to develop an antibody, STI-1499, to help in prevention of the coronavirus disease (COVID-19) in San Diego, California, May 22, 2020.


© Provided by CNBC
Research associate Sachi Johnson works at Sorrento Therapeutics where efforts are underway to develop an antibody, STI-1499, to help in prevention of the coronavirus disease (COVID-19) in San Diego, California, May 22, 2020.

All the fundamentals are aligning for the life sciences industry, as Covid-19 accelerates already growing demand for real estate in the sector.

Loading...

Load Error

Rents are rising for lab space, vacancies are plunging and research and development, and employment and new development are expanding further, thanks to strong venture capital investment. 

Read More Read more